Abstract:Objective: To investigate the inhibitor), effect of humanized anti-VEGFR-2 SoFv-As2O3-stealth nanoparticles conjugate on growth of human hepatocellular carcinoma both in vitro and in vivo, which may be a potential agents with sensitivity and targeting ability for human hepatocellular cancer. Methods: Humanized anti-VEGFR-2 SeFv-As2O3-stealth nanoparticles conjugate was previously constructed using ribosome display technology and antibody conjugate technology. In this combined in vitro and in vivo study, the inhibitory effects of anti-VEGFR-2 ScFv-As2O3- stealth nanoparticles conjugate on tumor growth, invasion: and metastasis was observed with human liver carcinoma cell line Bel7402 and normal cell L02 by MTT assay, Tanswell assay, Hochest33258 staining, and DNA ladder analysis. The anticancer activity and distribution of anti-VEGFR-2 ScFv-As2O3-stealth nanoparticles was then verified in a mouse model of Bel7402 xenografis. Results: anti-VEGFR-2 SoFv-As2O3-steahh nanoparticles significantly inhibited the proliferation of Bel7402 in the 3 (4,5-dimethylthiazol-2 yl)-2,5-diphenyltetrazolium bromide assay while had almost no effects on L02 cells. And the apoptosis inducing effects were proved by Hochest33258 staining and DNA ladder analysis. Transwell assay found that the drug also inhibited the metastasis ability of tumor cells. Furthermore, anti-VEGFR-2 ScFv-As2O3-stealth nanoparticles significantly delayed the growth of Bel7402 xenografts after administration (92.9%), followed by As2O3-stealth nanoparticles, anti-VEGFR-2 Say, and As2O3 (61.4%, 58.8%, 20.5%, P<0.05). The concentration of As2O3 in anti-VEGFR-2 ScFv-As2O3-stealth nanoparticles group was more selectively. Conclusions: Anti-VEGFR-2 SaFv-As2O3-stealth nanoparticles is a potent and selective anti hepatocellular carcinoma agent which could inhibit the growth of liver cancer as a targeting agent both in vitro and in vivo and also significantly inhibit angiogenesis.

In vitro and in vivo pharmacodynamic screening of novel vinflunine derivatives

Synthesis of Novel Spin-Labeled Derivatives of 5-FU As Potential Antineoplastic Agents

Antitumor Effects of Vinflunine

Antitumor Agents 288: Design, Synthesis, SAR, and Biological Studies of Novel Heteroatom-Incorporated Antofine and Cryptopleurine Analogues As Potent and Selective Antitumor Agents.

In Vitro and in Vivo Evaluation of the Antitumor Efficiency of Resveratrol Against Lung Cancer

Synthesis and biological evaluation of novel podophyllotoxin analogs as antitumor agents.

In Vitro and in Vivo Anticancer Activities of Folate-decorated Vinorelbine Bitartrate-loaded Recombinant Human Serum Albumin Nanoparticles

Antitumor and Antimetastatic Activities of a Novel Benzothiazole-2-thiol Derivative in a Murine Model of Breast Cancer

Inhibitory Effect of Humanized Anti-Vegfr-2 ScFv-As2O3-stealth Nanoparticles Conjugate on Growth of Human Hepatocellular Carcinoma: in Vitro and in Vivo Studies

Effect of resveratrol trinicotinate versus resveratrol against tumors in vitro and in vivo

Discovery of Novel Vinyl Sulfone Derivatives As Anti-Tumor Agents with Microtubule Polymerization Inhibitory and Vascular Disrupting Activities.

Synthesis and Structure-Activity Relationship Studies of Cytotoxic Vinorelbine Amide Analogues

Screening of Anti-Tumor Activity of Vandetanib Derivatives

Discovery of Novel Potent VEGFR-2 Inhibitors Exerting Significant Antiproliferative Activity against Cancer Cell Lines.

Design, Synthesis and Biological Evaluation of a Series of New Resveratrol Analogues As Potential Anti-Cancer Agents

A Novel Myricetin Derivative with Anti-cancer Properties Induces Cell Cycle Arrest and Apoptosis in A549 Cells.

Design, synthesis and preliminary biological evaluation of 3′,4′,5′-trimethoxy flavonoid salicylate derivatives as potential anti-tumor agents

The discovery of a novel compound with potent antitumor activity: virtual screening, synthesis, biological evaluation and preliminary mechanism study

Design, synthesis and in vitro anticancer research of novel tetrandrine and fangchinoline derivatives

Synthesis and biological evaluation of novel benzylidene-succinimide derivatives as noncytotoxic antiangiogenic inhibitors with anticolorectal cancer activity in vivo.

Design, Synthesis, and Biological Evaluation of Novel Apigenin Derivatives as Potential Antitumor Agents